Substance use and psychotic disorders, seizures, neurocognitive disorders (including Alzheimers disease and dementia), coagulation disorders, cardiometabolic disorders (heart attack, heart failure, ischemic stroke, and hemorrhagic stroke, pulmonary embolism, pulmonary hypertension, coagulopathy and clotting disorders) chronic kidney disease, COPD, pneumonia, liver failure, inflammatory bowel disease, liver cancer) all significantly declined
None ofthe interventions showed significant effects on HOMA-IR, and results were marked by heterogeneity
"Patients who combine medication with consistent lifestyle changesrather than relying on pharmacology aloneare more likely to achieve and maintain substantial, long-term health improvements." Nutrient intake is another thing to consider when starting GLP-1s
Margolina, GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration, Wiley, 2015
People starting at higher weights have more room to work with
If youre considering trying medicated weight loss to support your weight management journey, visit our website to find out which treatment may be best suited to you
